Malmö, Sweden – Acarix a global leader in AI and acoustics-based cardiac diagnostics, is pleased to announce that the first payor has agreed to provide fixed reimbursement for the CADScor® System at a rate of $300. This reimbursement applies to use in both physician office settings and outpatient/emergency department (ED) settings. The payor is a regional Third Party Administrator (TPA) based in Oklahoma, specializing in the administration of self-funded employee benefit plans.
Commenting on the milestone, CEO Aamir Mahmood stated:
“Our team has worked closely with this payor for nearly a year to achieve this outcome. It highlights both the complexity and perseverance required to secure fixed reimbursement for an innovative technology like CADScor—even when the clinical and economic value is clear. This agreement marks an important step forward and fulfills one of the key performance indicators (KPIs) we set for Q3, as outlined in my Q1 presentation just a few weeks ago.”
This achievement represents a critical validation of CADScor’s value proposition and strengthens Acarix’s position as a pioneer in early coronary artery disease detection.